GlassScriptPhysician profile
Dana A Mormann
NPI 1356914469
$685.95
in general payments reported to CMS, 2019-2025
11 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $101 · 2023: $132 · 2024: $299 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571 · Travel and Lodging: $14.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.50 |
| Travel and Lodging | $14.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $194.31 | 2022-2025 | Grafix Pl, Oasis, Stravix |
| Organogenesis INC. | $128.34 | 2022-2024 | Puraply Antimicrobial, Puraply |
| Urgo Medical North America, LLC | $92.02 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Medline Industries LP | $86.16 | 2024 | Medline |
| Kerecis Limited | $67.03 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Reprise Biomedical, INC. | $32.47 | 2025 | Miro3d |
| Convatec INC. | $31.52 | 2024-2025 | |
| Solventum Corporation | $20.07 | 2025 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Bsn Medical INC | $13.81 | 2024 | |
| Mimedx Group, INC. | $13.48 | 2025 | |
| Lifenet Health | $6.74 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Mormann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.